The renewal-value metric asks who decides whose youth is worth keeping

Who ages first? Ask it here, on the plaza outside the Earthside clinic, where the letters on the banner have faded to the color of everything left too long in the sun: THE LIST DOES NOT MOVE. THEY DO NOT LEAVE. The succession sit-in is in its fourth week. Inside, the Meridian Longevity Institute has agreed to review a proposal that would, at last, make the list move — for a price. Surrender your public office, sign a pledge to vacate, and a number called your "renewal value" carries you up the queue.

It's a tidy idea. Tidy ideas are the ones you should search hardest. Bioethicists call it dignified turnover. The young, who have waited long enough to grow into the institutions they were promised, call it overdue. The incumbents call it coercion — a remarkable word from people who've spent three decades declining to leave.

So let's do what the proposal doesn't. Follow the pen. A metric is not a principle. A metric is an author with a spreadsheet. Someone decides what renewal value measures. Someone decides its weights. Someone decides when to revise them. Three questions, then, and I want them printed together: Who assigns the number? Who audits the one who assigns it? And how many days after the number grows teeth does it get gamed?

The board that governs the list

We already know how this ends, because we can read the last version of it. The coastal cohort waitlist holds just over forty thousand names. Last quarter it moved 1.9 percent — a glacier's pace, in an age that has, incidentally, stopped the glaciers from melting. The board that governs that list has eleven members. Seven have received tier-one therapy. None has disclosed a place on any waitlist.

That's the existing metric. It's called "clinical prioritization," and it has produced a triage board where the majority already got what the forty thousand are waiting for. Now imagine that same species of committee handed a variable named renewal value and told to score which lives are worth keeping young. Ask who writes the rubric. Ask who reviews the rubric. Ask who benefits when the rubric stays vague.

The judge who will not leave

The proposal exists because of men like Chair-emeritus Aurelio Vance. Justice Vance is 130 years old. This month he declined retirement from the Charter Court for a third term, stalling the succession line beneath him and outlasting, by his own arithmetic, the patience of the people camped outside a clinic he has never had to queue at.

The Institute's own senior counsel has warned that tying therapy to resignation may violate the Accord's equal-access clause — that a therapy conditioned on leaving office is no longer equal access at all. She's right to worry. But notice the shape of the trap. If the metric is coercion, the incumbents keep their posts and their treatments both. If it's voluntary, the powerful buy their years and call it a choice. Either way, the pen stays in the same hands.

The review will accept submissions through the next transfer window. It will not suspend the existing waitlist while it deliberates. The forty thousand keep their places. Justice Vance keeps his. The number that would move either has not yet been written, and the last person to hold that pen hasn't put it down.